AMPH
Price
$22.37
Change
-$0.14 (-0.62%)
Updated
Jul 25 closing price
Capitalization
2.11B
16 days until earnings call
VTRS
Price
$9.41
Change
+$0.06 (+0.64%)
Updated
Jul 25 closing price
Capitalization
14.18B
12 days until earnings call
Interact to see
Advertisement

AMPH vs VTRS

Header iconAMPH vs VTRS Comparison
Open Charts AMPH vs VTRSBanner chart's image
Amphastar Pharmaceuticals
Price$22.37
Change-$0.14 (-0.62%)
Volume$329.13K
Capitalization2.11B
Viatris
Price$9.41
Change+$0.06 (+0.64%)
Volume$5.03M
Capitalization14.18B
AMPH vs VTRS Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. VTRS commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a StrongBuy and VTRS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (AMPH: $22.37 vs. VTRS: $9.41)
Brand notoriety: AMPH and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 68% vs. VTRS: 40%
Market capitalization -- AMPH: $2.11B vs. VTRS: $14.18B
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 4 bearish.
  • VTRS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both AMPH and VTRS are a good buy in the short-term.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а +8.49% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +5.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

AMPH is expected to report earnings on Aug 11, 2025.

VTRS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than AMPH($2.11B). VTRS has higher P/E ratio than AMPH: VTRS (238.80) vs AMPH (16.69). VTRS YTD gains are higher at: -22.370 vs. AMPH (-39.752). VTRS has higher annual earnings (EBITDA): 3.52B vs. AMPH (240M). VTRS has more cash in the bank: 1.18B vs. AMPH (257M). AMPH has less debt than VTRS: AMPH (624M) vs VTRS (18.4B). VTRS has higher revenues than AMPH: VTRS (15.4B) vs AMPH (644M).
AMPHVTRSAMPH / VTRS
Capitalization2.11B14.2B15%
EBITDA240M3.52B7%
Gain YTD-39.752-22.370178%
P/E Ratio16.69238.807%
Revenue644M15.4B4%
Total Cash257M1.18B22%
Total Debt624M18.4B3%
FUNDAMENTALS RATINGS
AMPH vs VTRS: Fundamental Ratings
AMPH
VTRS
OUTLOOK RATING
1..100
310
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
13
Undervalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
4594
PRICE GROWTH RATING
1..100
8856
P/E GROWTH RATING
1..100
921
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (13) in the null industry is somewhat better than the same rating for AMPH (63) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (97) in the Pharmaceuticals Other industry is in the same range as VTRS (100) in the null industry. This means that AMPH’s stock grew similarly to VTRS’s over the last 12 months.

AMPH's SMR Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for VTRS (94) in the null industry. This means that AMPH’s stock grew somewhat faster than VTRS’s over the last 12 months.

VTRS's Price Growth Rating (56) in the null industry is in the same range as AMPH (88) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew similarly to AMPH’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for AMPH (92) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew significantly faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHVTRS
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 16 days ago
70%
Bearish Trend 12 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMVYX14.230.08
+0.57%
Columbia Select Mid Cap Value Instl 3
VQNPX68.450.27
+0.40%
Vanguard Growth & Income Inv
ITEIX10.080.04
+0.40%
VY® T. Rowe Price Equity Income I
AEDNX12.540.01
+0.08%
Water Island Event-Driven Fund I
PQIRX26.76N/A
N/A
Victory Pioneer Equity Income R

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-1.15%
AMRX - AMPH
40%
Loosely correlated
+0.75%
VTRS - AMPH
32%
Poorly correlated
+0.64%
HROW - AMPH
32%
Poorly correlated
-2.81%
PAHC - AMPH
31%
Poorly correlated
-0.88%
DVAX - AMPH
31%
Poorly correlated
+1.79%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+0.64%
ELAN - VTRS
48%
Loosely correlated
+1.57%
AMRX - VTRS
45%
Loosely correlated
+0.75%
ZTS - VTRS
44%
Loosely correlated
-0.46%
PAHC - VTRS
38%
Loosely correlated
-0.88%
PBH - VTRS
36%
Loosely correlated
+0.79%
More